MedTrace Logo

Study of POMELLA™ Extract to Treat Prostate Cancer

NCT01100866 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2014-03-11

No results posted yet for this study

Summary

This is a randomized, two-arm, placebo controlled trial to evaluate benefit of treatment using POMELLA™ extract on mechanisms known to drive prostate cancer. This research allows provision for biochemical and histological comparisons to be made between POMELLA™ treated and placebo treated prostate tissues removed from men with organ confined prostate cancer.

Conditions

Interventions

DIETARY_SUPPLEMENT

POMELLA™ (pomegranate extract)

in a capsule form, 2 x 500mg once daily

OTHER

Placebo

placebo capsules

Sponsors & Collaborators

  • Lotte & John Hecht Memorial Foundation

    collaborator OTHER

  • Vancouver Coastal Health

    lead OTHER_GOV

Principal Investigators

  • Alan I So, MD, FRCSC · Vancouver Coastal Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2012-11-30
Completion
2012-11-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01100866 on ClinicalTrials.gov